With over 20 clinical trials for convalescent plasma therapy to treat coronavirus across the world, Lounge speaks to those geared up to begin trials in India, doctors and donors who are leading from the front In 1890, physiologist Emile von Behring discovered that convalescent blood plasma from once- infected rabbits could be used to treat diptheria in humans—initially, it was produced from immunized animals but soon whole blood or serum from recovered donors was identified as a possible source of specific antibodies of human origin.
More than a century and several clinical trials later, it is this same therapy that is showing promise as the world deals with a pandemic caused by a new virus.